PMC:7546122 / 9626-10085
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T46 | 70-76 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T47 | 105-111 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T48 | 204-210 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T49 | 318-324 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T40 | 41-49 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T41 | 225-233 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T42 | 298-306 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T93 | 70-76 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T94 | 105-111 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T95 | 143-149 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T96 | 176-183 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T97 | 187-188 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T98 | 204-210 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T99 | 318-324 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T100 | 423-424 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T66 | 0-150 | Sentence | denotes | To evaluate the potential development of SARS-CoV-2 antibodies in the plasma donor community, samples of plasma pools of 6 donations each were tested. |
| T67 | 151-285 | Sentence | denotes | The use of pools enabled testing of a high amount of plasma donations for SARS-CoV-2 nAbs with the biosafety level-3 functional assay. |
| T68 | 286-459 | Sentence | denotes | As the mean SARS-CoV-2 µNT50 of plasma donations is rather high (approximately 1:230 [9]) even the nAbs of only 1 positive sample within a pool are detectable in this assay. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 169 | 225-235 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 170 | 298-308 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 171 | 41-51 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 172 | 236-240 | Chemical | denotes | nAbs | |
| 173 | 385-389 | Chemical | denotes | nAbs |